Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Flutiform (fluticasone proprionate and formoterol fumarate) for Treatment of Asthma

Drug (Brand / Generic)

Flutiform / fluticasone proprionate and formoterol fumarate

Developed by

Mundipharma and SkyePharma

Therapy Class

Combination therapy

Current Indication


Market Sector

Respiratory diseases

Development Status

Approved in Ireland, UK, Netherlands, Germany, Cyprus, Iceland, Denmark, Sweden, Norway, Austria, Slovakia, Poland, Bulgaria, Finland and the Czech Republic

Go Top